Effector Therapeutics Inc (EFTR) — Financial Flexibility Index
Effector Therapeutics Inc (EFTR) has a Financial Flexibility Index of -0.28x as of March 2024. Free cash flow of $-7.28 Million (operating CF $-7.28 Million minus capex $0.00) represents 0% of total liabilities ($26.30 Million). Also explore how fast is Effector Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Effector Therapeutics Inc Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Effector Therapeutics Inc across 5 annual periods. Check asset allocation strategy of Effector Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Effector Therapeutics Inc (2019–2023)
Year-by-year free cash flow to debt coverage for Effector Therapeutics Inc. For the full company profile including market capitalisation, see Effector Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -1.12x | $-29.45 Million | $-29.55 Million | $26.34 Million | ▼ -9.5% |
| 2022 | -1.02x | $-25.71 Million | $-25.90 Million | $25.18 Million | ▼ -51.1% |
| 2021 | -0.68x | $-24.85 Million | $-24.89 Million | $36.77 Million | ▼ -819.4% |
| 2020 | 0.09x | $13.99 Million | $13.84 Million | $148.95 Million | ▲ +106.4% |
| 2019 | -1.46x | $-27.59 Million | $-27.60 Million | $18.93 Million | — |